Federal Consumer Protection Grants

This funding opportunity provides $1 million to various organizations to develop and implement strategies for effectively sharing clinical practice guidelines, particularly in underserved communities, to improve healthcare quality and equity.

This funding opportunity is designed to support collaborations between the FDA and the generic drug industry to advance research and development of complex generic medications, ultimately improving patient access to safe and effective drugs.

This funding opportunity is designed to help state animal food regulatory programs implement and maintain safety standards, fostering collaboration between state and federal agencies to create a unified animal food safety system.

This funding opportunity provides financial support to state and local governments, tribal entities, and accredited educational institutions to enhance their food testing laboratories' capabilities and improve national food safety through advanced testing and emergency response initiatives.

This funding opportunity provides financial support to various organizations, including universities and non-profits, to improve veterinary diagnostic capabilities and address public health issues related to animal food safety and antimicrobial resistance.

This funding opportunity supports a variety of organizations in conducting innovative research to develop medical products for preventing, diagnosing, and treating ALS and other rare neurodegenerative diseases.

This funding opportunity provides up to $1 million for various organizations to develop innovative projects that improve diversity and inclusivity in clinical trials, enhance data on underrepresented groups, and capture diverse patient perspectives to promote health equity.

This funding opportunity provides $4 million to nonprofit national organizations affiliated with higher education that work with state and local regulatory personnel to improve food safety practices and reduce foodborne illnesses in retail environments across the U.S.

This funding opportunity provides $250,000 to various organizations to develop educational programs that raise awareness about the health risks of skin lightening products and promote safer alternatives in communities.

This funding opportunity provides financial support for clinical trials aimed at developing new treatments for rare neurodegenerative diseases, targeting a wide range of eligible applicants including universities, nonprofits, and government entities.

This funding opportunity is designed to support academic research institutions in developing innovative solutions to combat animal diseases, enhance agricultural resilience, and address unmet veterinary medical needs.

This grant provides funding to various organizations, including governments and educational institutions, to promote research and initiatives that improve health equity for racial and ethnic minority populations.

This grant provides funding to federal and state agencies to improve animal food safety programs through collaboration, training, and the development of best practices.

This funding opportunity supports clinical trials aimed at developing new therapies for rare neurodegenerative diseases, such as ALS, and is open to a wide range of eligible organizations, including universities and nonprofits.

This funding opportunity provides $2 million to a variety of organizations for research projects focused on improving pain management, anesthesia safety, and addiction treatment strategies.

This Notice of Funding Opportunity (NOFO) is issued by the Food and Drug Administration (FDA), Center for Veterinary Medicine (CVM), and solicits Research Project (R01) grant applications from institutions or organizations that propose to develop or support the development of designated new animal drugs intended for minor uses in major species or for use in minor species (MUMS). The FDA is authorized to provide grants to assist in defraying the costs of qualified safety and effectiveness testing that could be used to satisfy the requirements for FDA approval of MUMS-designated drugs.Only entities developing drugs for veterinary use or parties working as research partners with such entities are eligible for grants.The organization (or applicant) seeking approval of the new animal drug under investigation must have opened an Investigational New Animal Drug (INAD) file with FDA/CVM and must hold a minor use or minor species "designation" granted by FDA/CVM's Office of Minor Use and Minor Species Animal Drug Development (OMUMS) for that drug for a specified intended use, in accordance with the provisions of section 573 of the Food, Drug and Cosmetic Act (21 U.S.C. 360ccc-2) and 21 CFR part 516.FDA/CVM's Office of New Animal Drug Evaluation (ONADE) must have reviewed and concurred with the proposed study protocol before an applicant can submit a grant application.

This funding opportunity supports organizations that provide free or low-cost tax assistance and education to low-income individuals and those with limited English proficiency, ensuring fair access to the tax system.

In 2023, FBIs Internet Crime Complaint Center (IC3) received a record number of complaints from the American public: 880,418 complaints were registered, with potential losses exceeding $12.5 billion. This is a nearly 10% increase in complaints received, and it represents a 22% increase in losses suffered, compared to 2022. Small businesses are attractive targets because they have information that cybercriminals want, and they typically lack the security infrastructure of larger businesses. Surveys have shown that many small business owners feel their businesses are vulnerable to a cyberattack. Yet many businesses cannot afford professional IT solutions, have limited time to devote to cybersecurity, or do not know where to begin. The Consolidated Appropriations Acts, 2022, 2023 and 2024, authorized the U.S. Small Business Administration to make grants to States, and the equivalent thereof, to carry out projects that help new small business concerns with tools to combat cybersecurity threats during their formative and most vulnerable years.

The Food and Drug Administration's (FDA) Center for Food and Safety and Applied Nutrition (CFSAN) is announcing its intention to receive and consider a single source application for the award of a cooperative agreement in fiscal year 2024 to Cornell University to support the Center for Veterinary Medicine and the College of Agricultural and Life Sciences. The purpose of this support is to:1. Carry out multidisciplinary applied research projects on raw milk cheese aging to examine factors that affect Highly Pathogenic H5N1 Avian Influenza (HPAI H5N1) virus inactivation, to include pH and water activity.2. Carry out multidisciplinary applied research projects on commonly used acidification methods for treatment of waste milk to be fed to calves, or for disposal, to understand effects on HPAI H5N1.3. Carry out multidisciplinary applied research projects to characterize the thermal inactivation kinetics of HPAI H5N1 in a wide variety of dairy products.4. Provide additional capabilities and capacity for HPAI H5N1 testing as needed to help meet the needs of FDA's research agenda. 5. Engage with academic and industry stakeholders to help ensure work is complementary of other ongoing research in these research spaces and to facilitate the use of the information produced by the research program.

The Food and Drug Administration (FDA)/ Center for Food and Safety and Applied Nutrition (CFSAN) is announcing its intention to receive and consider a single source application for the award of a cooperative agreement in fiscal year 2024 to the Illinois Institute of Technology to support the Institute for Food Safety and Health (IFSH). The purposes of this continued support are to:1. Carry out multidisciplinary applied research projects on pre- and postharvest processing preventive control measures, on food processing and packaging technologies, on the impact of these processing strategies on the nutritional quality of food, and on laboratory method performance (including method validation) that address research needs associated with FDA-regulated products, fill knowledge gaps identified in prevention strategies, and that are consistent with the Deputy Commissioner of Foods vision for the implementation of the new Human Foods Program (HFP) Science and Research Strategic Plan;2. Maintain and facilitate the further development of the IFSH collaborative research program by leveraging resources among U.S. government agencies, universities (including other IIT components), and the food industry to achieve practical Food Safety Modernization Act (FSMA)-based, technology-enabled New Era of Food Safety solutions to food safety and food processing issues.3. Engage with stakeholders to develop and implement training, outreach and communication programs, to identify research needs, and to facilitate the use of the information produced by the research program; and4. Support the implementation of the new unified HFP FSMA-based New Era of Food Safety priorities through research, education, and outreach, with emphasis on the development of strategies for prevention, exploration of opportunities for data sharing, and adoption of root cause analysis (RCA) into agency post-response efforts associated with the safe and sustained manufacturing, processing, packing, and holding of food.